The nasal vaccine against COVID-19

iNCOVACC is a novel adenovirus vectored, intranasal vaccine for COVID-19. It has various advantages over injectable vaccines. Here are a few of them.

The two-drop nasal vaccine, iNCOVACC is manufactured by Bharat Biotech, India. It is a novel adenovirus vectored, intranasal vaccine for COVID-19 that can stimulate a broad immune response – neutralizing IgG, mucosal IgA, and T cell responses. 

How does it work?

The nasal vaccine is delivered through the nose or mouth. It is expected to work on the mucosal lining. Thus, the nasal vaccine prompts an immune response at the entry points of the virus which is mostly the nose and the mouth. This prevents infection at the entry point itself thereby protecting against disease, infection, and transmission. It is referred to as sterilizing immunity. Many studies have found that nasal delivery of vaccines is capable of creating a strong immune response.

Mice, Hamsters and macaques were immunized with a single dose of ChAd-SARS-CoV-2-S conferred superior protection against the SARS-CoV-2 challenge. Post-challenge with SARS-CoV-2, viral clearance was observed in both lower and upper airways in all these animal models.

Nasal vaccines v/s Injectable vaccines

Nasal vaccines have a proven benefit over injectable vaccines. In the third phase of the clinical trial which was done on 3,000 participants, iNCOVACC showed good immunity with 2 doses given 4 weeks apart.

Advantages of the nasal vaccine

  • An immune response at the site of infection is essential for blocking both infection and transmission of COVID-19.
  • Non-invasive, Needle-free
  • Ease of administration – does not require trained healthcare workers
  • Elimination of needle-associated risks (injuries and infections)
  • High compliance

Nasal vaccine composition

0.5 ml of this nasal vaccine contains NLT 5X10 particles per mL ChAd36-SARS-CoV-S COVID-19 virus (recombinant) including excipients such as Tris (pH 7.4), Sodium Chloride, Magnesium Chloride, Glycerol, Polysorbate- 80.

Those who have taken Covishield and Covaxin can take the nasal vaccine as a heterologous booster dose. In heterologous boosting, a person administered a different vaccine from the one that was used for the primary dose series.

The nasal vaccine as a booster dose and not the fourth dose after the booster shot

The nasal vaccine is recommended as a first booster and cannot be administered after one has taken the booster or the precautionary dose. This is because by repeatedly immunizing with a particular type of antigen, the body stops responding or responds poorly. Therefore, taking the nasal vaccine as the fourth dose after taking the booster dose is of no value.

Tags : #COVID19 #Nasalvaccine #Vaccination #VaccineforCOVID19 #iNCOVACC #MadeinIndiavaccine #NasalvaccineforCOVID19 #Medicircle #SmitaKumar

About the Author


Renu Gupta

With a background in Pharmacy which is the clinical health science that links medical science with chemistry, I had the desire to mix creativity to these fields. Medicircle provides me an avenue to apply my training in science and interest in creativity together.

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Actor-Director Sathish Kaushik Died of a Heart Attack at the Age of 66March 09, 2023
Soleus Push-Ups: A Laziest Exercise to Lower Blood Sugar LevelsMarch 09, 2023
World Kidney Day 2023: Be Aware of Kidney DiseasesMarch 09, 2023
Sushmita Sen reveals about suffering from a severe heart attack recently and Addison's disease in 2014March 06, 2023
A significant increase in influenza A H3N2 patients that are accompanied by severe coughing and feverMarch 06, 2023
Is AIDS or HIV curable in Ayurveda?March 03, 2023
Artificial Sweetener Erythritol Raises the Possibility of Heart Attack.March 01, 2023
Difference between HIV and AIDS - When to give antiretroviral therapy?March 01, 2023
Zero Discrimination Day: Let's Raise the Voice Against DiscriminationMarch 01, 2023
International Women’s Day 2023 – Embrace EquityFebruary 28, 2023
Brain Tumors - Types, Symptoms and Risk FactorsFebruary 28, 2023
World Rare Disease Day: End Stigma Against Rare Diseases.February 28, 2023
National Science Day 2023 - Global Science for Global WellbeingFebruary 28, 2023
Eating disorders - Types and their complicationsFebruary 27, 2023
The condition that took away the life of Malayalam filmmaker, Joseph ManuFebruary 27, 2023
World NGO Day 2023 - We make a living by what we get, but we make a life by what we giveFebruary 27, 2023
Functions and Problems of SerotoninFebruary 25, 2023
Arthritis management – Tips to manage arthritis effectivelyFebruary 25, 2023
Apple has undertaken a project of no-prick blood sugar monitoring feature for its watch.February 24, 2023
Bird flu – Jharkhand on alert, know its prevention and symptoms in humansFebruary 24, 2023